Efficacy and Safety of Duodenal Stenting for Malignant Gastric Outlet Obstruction: Insights From a 15‐year Single‐Center Experience
DEN Open · 2026-04 · 6 (1)
DOI: 10.1002/deo2.70192 ↗Kurz gefasst
Fachartikel in der Zeitschrift DEN Open, online erschienen am 25.08.2025. Verfasst von Masatoshi Murakami und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Bioregulatory Science Graduate School of Medical Sciences, Kyushu University Fukuoka Japan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
Endoscopic duodenal stent (DS) placement has become a primary palliative approach for malignant gastric outlet obstruction (MGOO), offering minimally invasive symptom relief. However, complications and risk factors for stent dysfunction and prognostic indicators of survival are not fully elucidated.
Methods
We retrospectively analyzed 114 patients who underwent initial DS placement for MGOO at Kyushu University Hospital between January 2010 and October 2024. Clinical outcomes, stent patency, and survival predictors were analyzed. The primary endpoint was stent patency; overall survival (OS) was a secondary endpoint.
Results
Pancreatic cancer was the most common underlying malignancy (77.2%). Technical and clinical success rates were 99.1% and 84.1%, respectively; the overall clinical success rate reached 91.2% after additional stenting in initially unsuccessful cases. Adverse events occurred in 12.3% of patients. Among 104 patients with overall clinical success, 18 patients (17.3%) experienced stent dysfunction. Median stent patency and OS were 14.8 and 2.8 months, respectively. Pre‐existing biliary stricture and stent placement across the pylorus were significantly associated with reduced stent patency. High neutrophil‐to‐lymphocyte ratio predicted poorer survival, whereas type III stenosis and post‐stenting chemotherapy were linked to improved survival. No significant differences in outcomes were observed between early and late treatment periods. Reintervention with DS was safe and effective, and 93.3% of patients maintained GOO control with DS alone.
Conclusions
Duodenal stenting is a safe and effective palliative intervention for MGOO. Incorporating inflammation‐based biomarkers and individualized treatment strategies can help optimize patient selection and improve survival outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine and Bioregulatory Science Graduate School of Medical Sciences, Kyushu University Fukuoka Japan.
- Department of Gastroenterology Clinical Research Institute, National Hospital Organization Kyushu Medical Center Fukuoka Japan.
ORCID-Profile: Masatoshi Murakami
Zitieren
APA
Murakami, M., Fujimori, N., Suenaga, A., Ueda, T., Kakehashi, S., Furuta, A., Ohno, A., Matsumoto, K., Takamatsu, Y., Ueda, K., & Ogawa, Y. (2026). Efficacy and Safety of Duodenal Stenting for Malignant Gastric Outlet Obstruction: Insights From a 15‐year Single‐Center Experience. DEN Open, 6(1). https://doi.org/10.1002/deo2.70192
Vancouver
Murakami M, Fujimori N, Suenaga A, Ueda T, Kakehashi S, Furuta A, et al. Efficacy and Safety of Duodenal Stenting for Malignant Gastric Outlet Obstruction: Insights From a 15‐year Single‐Center Experience. DEN Open. 2026;6(1). doi:10.1002/deo2.70192
BibTeX
@article{Murakami2026,
author = {Murakami, Masatoshi and Fujimori, Nao and Suenaga, Akihiko and Ueda, Takahiro and Kakehashi, Shotaro and Furuta, Akito and Ohno, Akihisa and Matsumoto, Kazuhide and Takamatsu, Yu and Ueda, Keijiro and Ogawa, Yoshihiro},
title = {Efficacy and Safety of Duodenal Stenting for Malignant Gastric Outlet Obstruction: Insights From a 15‐year Single‐Center Experience},
journal = {DEN Open},
year = {2026},
volume = {6},
number = {1},
doi = {10.1002/deo2.70192}
}
EUVIMED